H.C. Wainwright reiterates Buy rating on Agenus stock after promising ESMO data
PositiveFinancial Markets

H.C. Wainwright has reaffirmed its Buy rating on Agenus stock following encouraging data presented at the ESMO conference. This positive outlook is significant as it reflects confidence in Agenus' potential in the biotech sector, which could attract more investors and drive the stock price higher. The promising results from ESMO could pave the way for future developments and partnerships, making it an exciting time for both the company and its shareholders.
— Curated by the World Pulse Now AI Editorial System